The Food and Drug Administration (FDA) performed an inspection at Bucher Vaslin North America, Inc. in Santa Rosa on Feb. 6 to assess risks related to foodborne biological hazards, according to data posted on the FDA’s website.
The final report recommended that Bucher Vaslin North America, Inc. implement voluntary corrective actions to enhance management operations.
The FDA routinely inspects facilities across the country to evaluate whether workplaces and products comply with laws and regulations designed to protect public health. Inspection outcomes are shared with the public.
According to its website, the FDA is a federal agency mainly responsible for overseeing the safety and quality of human and animal drugs, biological products, medical devices, and tobacco products.
Information in this article was obtained from the U.S. Food and Drug Administration. The source data can be found here.
